2026Cancer Letters
Team

Biography
Dr. Chu-Ling HU is a postdoctoral researcher at the Sixth Affiliated Hospital of Sun Yat-sen University. He completed his doctoral training in surgery in 2026 and studies colorectal cancer through bioinformatics, deep learning, and clinically useful AI model development.
Research Interests
- Colorectal Cancer
- Artificial Intelligence
Education
- Postdoctoral ResearcherThe Sixth Affiliated Hospital of Sun Yat-sen University2026 - Present
- Doctor of Medicine in SurgerySun Yat-sen University2021 - 2026
- Bachelor of Medicine in Clinical MedicineSun Yat-sen University2016 - 2021
Lab highlights
Highlighted publications
2025Advanced Science
CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self-Supervised Learning
2025Nature Communications
Personalized risk stratification in colorectal cancer via PIANOS system
All related publications
Conference PaperMay 1, 2026Gastroenterology
UNRAVELING THE IMPACT OF INSOMNIA ON COLORECTAL CANCER: MICROBIOME DYSBIOSIS, IMMUNOSUPPRESSIVE MICROENVIRONMENT, AND THERAPEUTIC IMPLICATIONS
Journal ArticleMar 11, 2026Cancer Letters
Multi-omics driven immune classification of colorectal cancer: Implications for immunotherapy efficacy prediction and enhancement with WNT signaling inhibition
Journal ArticleJan 21, 2026Cell Death & Disease
Lactylation of SLC26A3 in the acidic tumor microenvironment promotes malignant progression of colorectal carcinoma
Journal ArticleJan 14, 2026Diagnostics
Translating Molecular Subtypes into Cost-Effective Radiogenomic Biomarkers for Prognosis of Colorectal Cancer
Journal ArticleJul 23, 2025Advanced Science
CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self-Supervised Learning
Journal ArticleJul 16, 2025Nature Communications
Personalized risk stratification in colorectal cancer via PIANOS system
Du Cai†, Haoning Qi†, Qiuxia Yang†, Huayu Li†, Cheng-hang Li, Chuling Hu, Baowen Gai, Xu Zhang, Yize Mao*, Feng Gao*, Xiaojian Wu*
Journal ArticleMar 7, 2025Advanced Science
Interpretable Multimodal Fusion Model for Bridged Histology and Genomics Survival Prediction in Pan-Cancer
Feng Gao†, Junxiang Ding†, Baowen Gai†, Du Cai†, Chuling Hu, Feng-Ao Wang, Ruikun He, Junwei Liu*, Yixue Li*, Xiao-Jian Wu*
Journal ArticleSep 1, 2024International Journal of Surgery
Deciphering Tertiary Lymphoid Structure Heterogeneity Reveals Prognostic Signature and Therapeutic Potentials for Colorectal Cancer: A Multicenter Retrospective Cohort Study
Journal ArticleJun 26, 2023MedComm
Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies
Min-Yi Lv†, Du Cai†, Cheng-Hang Li†, Junguo Chen†, Guanman Li, Chuling Hu, Baowen Gai, Jiaxin Lei, Ping Lan*, Xiaojian Wu*, Xiaosheng He*, Feng Gao*
Conference PaperMay 1, 2023Gastroenterology
Senescence-Based Colorectal Cancer Subtyping Reveals Distinct Molecular Characteristics and Therapeutic Strategies
Journal ArticleApr 1, 2023Cancer Medicine
An immune, stroma, and epithelial--mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II--III colorectal cancer
Journal ArticleSep 7, 2022Frontiers in Genetics
Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
Conference PaperJun 1, 2022Journal of Clinical Oncology
A tumor immune microenvironment-related lncRNA signature for the prognosis and immunotherapeutic sensitivity prediction in colorectal cancer.
Journal ArticleMay 12, 2022Frontiers in Genetics
Multi-size deep learning based preoperative computed tomography signature for prognosis prediction of colorectal cancer
Journal ArticleMar 11, 2022Frontiers in Genetics
DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
Conference PaperMay 20, 2021Journal of Clinical Oncology
Deep learning to identify a gene signature associated with molecular subtypes that predicts prognosis in colorectal cancer.
Conference PaperMay 20, 2021Journal of Clinical Oncology
A model combing an immune-related genes signature and an extracellular matrix-related genes signature in predicting prognosis of left-and right-sided colon cancer
Conference PaperMay 20, 2021Journal of Clinical Oncology